The myogenic regulatory genes Myf5, Mrf4, Myod, and Myogenin likely arose by gene duplications during evolution, presumably to address the more demanding requirements of the vertebrate body plan. Two cell lineages were proposed to be regulated independently by Myf5 and Myod to safeguard against tissue failure. Here we report severe muscle loss following ablation of Myf5-expressing cells. Using both lineage-specific and ubiquitous reporter alleles, we show that the remaining muscles in Myf5
INTRODUCTION
Gene duplications of critical regulatory genes during evolution likely arose to assure the establishment and diversification of tissues as well as survival of the organism in detrimental conditions. Studies in skeletal myogenesis have provided insights into this design where the three cell fate determinants Myf5, Myod, and Mrf4 can each autonomously govern myogenic cell identity. Genetic studies in mice where all three genes are compromised in function showed that myoblasts and differentiated cells fail to develop (Kassar-Duchossoy et al., 2004; Rudnicki et al., 1992) . Mice mutant for the fourth member of this bHLH family, Myogenin, exhibit major differentiation deficits (Tajbakhsh and Buckingham, 2000) . The requirement for several cell fate regulators is intriguing, and can be explained in part by their distinct temporal and spatial patterns of activation during myogenic lineage progression (Cossu et al., 1996; Goldhamer et al., 1995; Ott et al., 1991; Sassoon et al., 1989; Tajbakhsh and Buckingham, 2000; Tajbakhsh et al., 1997) . For example, during development, Myf5 expression is highest in the embryonic phase, and it is downregulated during differentiation, whereas Myod is expressed in both embryonic and fetal myoblasts and myofibers (Murphy and Kardon, 2011; Tajbakhsh and Buckingham, 2000) . In addition, while loss of function of the major myogenic determinants Myf5 or Myod results in skeletal myogenesis in virtually all anatomical locations Kablar et al., 1997; Rudnicki et al., 1992; Tajbakhsh et al., 1997) , fetal myogenesis fails in Myf5:Myod double mutants (Kassar-Duchossoy et al., 2004) , demonstrating that these factors can functionally compensate for each other to a large extent.
An unresolved question for many tissues, including skeletal muscle, is whether different fate determinants act within a single, or in distinct cell lineages ( Figure 1A ). For example, Neurogenin1 and Neurogenin2, bHLH genes that act in the nervous system, were reported to govern distinct sensory cell populations in the chick and mouse (Frank and Sanes, 1991; Ma et al., 1999) . Similarly, studies in skeletal myogenesis lead to the proposal that independent progenitor cell lineages functionally incorporate either of the two major regulators, Myf5 or Myod, thereby providing a failsafe mechanism during tissuegenesis ( Figure 1A ). Specifically, ablation of Myf5-expressing cells in an in vitro ES cell differentiation model (Braun and Arnold, 1996) , and genetic ablation studies in mice using a conditionally activated diphtheria toxin gene (Gensch et al., 2008; Haldar et al., 2008) were found to be compatible with myogenesis. A pool of Myod + progenitors that did not express Myf5 by lineage tracing criteria was proposed to compensate for this loss in cranial and somitic mesoderm-derived muscles. These observations could therefore explain in part the requirement for several cell fate determinants and suggest that during evolution, duplications in myogenic regulators (Atchley et al., 1994; Zhao et al., 2014) might have correlated with a duplication of the respective progenitor cell populations.
A two-lineage model is difficult to reconcile with a recent report showing that DTA-mediated ablation of Myod-expressing cells results in complete loss of muscle at all anatomical locations (Wood et al., 2013) . However, because this result does not formally exclude the possibility of a Myod + /Myf5-independent lineage, resolving these progenitor cell relationships is critical to understand the dynamics of myogenic cell populations during muscle ontology. Furthermore, this information will affect the interpretation of adult muscle stem cell heterogeneity, and phenotypes of mutants that affect this cell population (Gü nther et al., 2013; Kuang et al., 2007; von Maltzahn et al., 2013) .
Although both somitic and cranial mesoderm-derived muscles have a critical requirement for the three myogenic determination genes, the use of distinct upstream gene regulatory networks in founder stem cells (Pax3 in trunk and limbs; Tbx1 and Pitx2 in cranial mesoderm; Harel et al., 2009; Kelly, 2013; Sambasivan et al., 2009 Sambasivan et al., , 2011 raises the possibility that local progenitor cell lineages might also be diverse. Given our previous genetic studies defining distinct gene regulatory networks in cranialand somite-derived muscles (Sambasivan et al., 2009) , we originally performed Myf5
Cre -driven cell ablation to examine cranial muscle progenitor fates. Unexpectedly, we found severe loss of muscle not only in the head, but also in major muscle groups throughout the organism, implying that if a Myod + /Myf5-independent population was present, it did not functionally compensate as reported previously (Gensch et al., 2008; Haldar et al., 2008) . By tracing Myf5 progenitors following cell ablation with a number of sensitive reporters, we demonstrate that 100% elimination of Myf5-expressing cells cannot be achieved, and instead we propose that Myf5 + escaper cells masquerade as an independent Myod + population. Together with the data obtained in a Myod null background, we propose that if a Myod + / Myf5-independent population exists, it is not functionally robust, and thus, not compatible with a two lineage model.
RESULTS

Severe Loss of Muscle in Myf5
Cre -DTA Mice
Previous studies used two different Myf5 Cre alleles (Haldar et al., 2007; Tallquist et al., 2000) and two R26 DTA mice (one with an attenuated DTA; Brockschnieder et al., 2004; Wu et al., 2006) to ablate Myf5-expressing cells (Gensch et al., 2008; Haldar et al., 2008) . Skeletal muscles were reported to be initially lacking in the embryo, but this phenotype was rescued and muscles were virtually normal in the fetus. Because the focus of those studies was largely trunk and limb muscles with limited attention to cranial muscles, we assessed the progenitor cell relationships in the head in more detail, where distinct gene regulatory networks initiate myogenesis. We used the same Myf5 Cre alleles (Myf5
CreCAP and Myf5 CreSOR ; Haldar et al., 2007; Tallquist et al., 2000) crossed with R26 DTA mice in which cell death was reported to occur in less than 24 hr after recombination (Ivanova et al., 2005) ; referred to here as: Myf5
Cre -DTA. Interestingly, the masseter and temporalis, which are two of the major muscle groups in the head, were entirely lacking or severely reduced in size ( Figure 1B ; Figure S1A available online; and data not shown). Extraocular and other cranial muscle phenotypes also ranged from total absence to severe muscle loss depending on the
Myf5
Cre line used ( Figure 1C ; Figure S1B , see below). Approximately 80% of the Myf5 CreCAP/+ :R26 DTA/+ fetuses examined (n = 6, embryonic day 14.5 [E14.5]; n = 13, E18.5) displayed a cleft of the secondary palate ( Figure 1B ; Figures S1A and S1C), which is consistent with a requirement for mechanical stimuli from the adjacent masseter for proper palatogenesis (Rot and Kablar, 2013; Rot-Nikcevic et al., 2006 Figure S1C ; and data not shown). Therefore, progenitor cells were also lacking in regions where muscle masses were lost in Myf5
Cre -DTA embryos. Unexpectedly, analysis of limb and trunk muscles at E18.5 also revealed severe muscle loss ( Figure 1D , and Figure S1D ). In general, forelimbs were more severely affected than hindlimbs (not shown). Accordingly, 100% of the Myf5 CreCAP/+
:R26
DTA/+ fetuses examined showed relaxed forepaws, reduced dorsiflexion, and lack of deltoid tuberosity ( Figure 1E , n = 55; and Figure S1E , n = 7), which are phenotypes resulting from loss of muscle masses (Blitz et al., 2009; Nowlan et al., 2010; Rot-Nikcevic et al., 2006) . We performed immunostainings for skeletal muscle-specific myosin heavy chain (MyHC) on transverse forelimb cryosections of E18.5 control and Myf5
CreCAP
-DTA fetuses at different levels along the proximo-distal axis ( Figure 1D ). Quantifications of the MyHC positive area per cross-sectional area showed a significant reduction in the total muscle area in Myf5
CreCAP -DTA fetuses ( Figure 1F ), in agreement with the observations in E14.5 embryos (Figures S1F and S1G). As with ablated cranial muscles, no Pax7
+ cells were present at sites of muscle loss (data not shown). Therefore, cranial-and somite-derived muscles were ablated using both Cre alleles, indicating that myogenesis was not completely rescued by a second Myf5-independent progenitor population as previously reported. We note that although all muscle groups were not missing in every fetus examined, collation of data across large sample sizes (n > 24 embryos cryosectioned, n = 55 animals total) showed that several muscle groups were susceptible to partial or full loss, independent of body region ( Figure 1G and data not shown). As a striking example, the esophagus, which contains a layer of circular and longitudinal skeletal muscles, totally lacked skeletal muscles in all Myf5
CreCAP -DTA fetuses, with no rescue at any stage examined (n = 7; Figure 1H ). These observations raised questions as to why all muscles groups were not ablated with the genetic combinations used. We therefore performed combinations of expression analysis and independent genetic validation experiments to address this point and reconcile our results with those of previous reports where muscles were reported to be virtually normal in Myf5 Cre -DTA fetuses (Gensch et al., 2008; Haldar et al., 2008) . (Cossu et al., 1996; Tajbakhsh et al., 1996a; Tajbakhsh and Buckingham, 2000) . Strikingly, we found significant amounts of X-gal-stained Myf5 nlacZ -positive cells persisting in virtually all anatomical locations with both Cre alleles (Figure 2A ). This result was unexpected given that Myf5 expression is highest between E8.5 and E11.5 (Ott et al., 1991) and efficient cell Figure S2A ). We then used our recently reported sensitive, lineage-specific, Pax7-driven reporter allele as a control for monitoring recombination efficiency (Pax7 nGFP-stop-nlacZ hereafter called Pax7
GPL
; Sambasivan et al., 2013) . Given that Pax7 is expressed in skeletal muscle stem/progenitor cells, accessibility of this locus to Cremediated recombination allows higher sensitivity for tracking cells within the muscle lineage (Relaix and Zammit, 2012; Sambasivan et al., 2013 (Sambasivan et al., 2013) and Myod (Kanisicak et al., 2009) and Pax7 GPL reporters showed severe loss of muscle following ablation of Myf5-expressing cells, similar to the data in Figure 1 in the absence of any reporter. One issue using this ablation strategy concerns the timing of Myf5-expression and the time required for DTA to kill these cells. We note that with both of these reporters, X-gal + nuclei were observed within surviving myofibers in all body locations ( Figure S2F and data not shown).
Because Myf5 is not expressed in myofibers Ott et al., 1991; Tajbakhsh and Buckingham, 2000) , and in accordance with the persistence of these X-galstained muscles in the fetus, we expect that the muscles that were derived from Myf5-expressing cells would no longer be ablated. Despite extensive studies with both Myf5 and Pax7, haploinsufficiency has not been reported for these genes during prenatal myogenesis (Relaix and Zammit, 2012; Shi and Garry, 2006; Tajbakhsh and Buckingham, 2000; Yin et al., 2013) . Nevertheless, to circumvent an unanticipated haploinsufficiency issue entirely, in particular in the context of cell ablation, we performed complementary experiments using whole-mount MyHC stainings in the absence of reporters ( Figure 2C ). These stainings gave the same results as quantifications on tissue sections (Figure 1D ), namely severe loss or reduction in muscles in Myf5
Cre -DTA fetuses. Higher variation between individuals and higher amounts of muscle remained with Myf5 CreSOR , which is likely due to higher numbers of Myf5 + escapers (see Figures   S2H and S2I). Importantly, the b-gal + cells that remained following ablation using the Myf5 nlacZ and Pax7 GPL reporters did not stain for cleaved-caspase3 at E12.5, E13.5, and E14.5, indicating that these cells were not dying at these relatively late Sections at different levels of the proximo-distal axis of the forelimb zeugopod are depicted as L1, L2, and L3 (see Figure S1E ). R, radius, U, ulna (bones frequently trap antibody Figure 3B ; p values on Figure S3A ). We note here that a major fraction of b-gal À Myod + cells were also Myogenin + (83% at E12.5, n = 3); therefore, differentiated and exited the cell cycle (data not shown). By E14.5, the situation evolved significantly. b-gal + Myod + cells (Myf5-derived nonkilled) expanded substantially and contributed to 50% of the total Myod + population in Myf5 Cre -DTA embryos, with half of these cells still in proliferation ( Figure 3B ). Therefore, these data suggest that by E14.5, two apparent subpopulations (Myf5-derived and Myf5-independent) contribute to similar extents to muscle rescue in Myf5
Cre -DTA embryos. We note that the presumed Myf5-independent population was designated as such based solely on reporter negativity. Figure S4A , data not shown). Different Rosabased reporters are known to have variable susceptibility for recombination (Liu et al., 2013 Scale bars in (A) represent low power 100 mm, high powers 25 mm. See also Figure S3 .
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Cre expression with in situ hybridization (ISH). Using a 5 0 UTR probe for Myf5 transcripts and in accordance with the persistence of Myf5-reporter + cells noted above, significant levels of endogenous Myf5 transcripts were observed in somites and limbs of E10.5 Myf5 Cre -DTA embryos ( Figure 4A ). Importantly,
Cre expression was severely reduced and constituted only a subset of Myf5 expression pattern even in control nonablated embryos. Expression of Myod was also reduced in Myf5 Cre -DTA embryos, indicating that DTA ablation was functional and a high proportion of Myod-expressing cells were Myf5-derived ( Figure 4A) Figure 4C ). Myf5 and Cre were coexpressed to a certain extent in trunk muscle masses of E11.5 and E12.5 control embryos. At E13.5, Cre protein was not detected in wild-type embryos in the trunk, consistent with the downregulation of the Myf5 locus at this stage; however, cells expressing low levels of Cre were detected in the limbs, which is consistent with the normal developmental timing for Myf5 expression in this location (data not shown). In agreement with the data presented above, we found that Myf5 + cells persisted in the trunks of E11.5, E12.5, and E13. Figure 5A ). Higher numbers of Pax7 + cells were observed among the muscle masses of Myod À/À fetuses, with or without cell ablation, in agreement with previous analyses of Myod null adult mice (Asakura et al., 2007; Macharia et al., 2010 ; Figure 5A ). Extraocular and trunk muscles were also present in E13.5 and E18. Cre -DTA embryos.
DISCUSSION
How tissues are established from stem and progenitor cell populations and how this ontology contributes to the adult stem cell pool remain a major unresolved question for most tissues. The observation that adult muscle stem cells are heterogeneous (Kuang et al., 2007; Rocheteau et al., 2012; Shinin et al., 2006; Tajbakhsh, 2009 ) raises the possibility that distinct founder cell populations that persist during development give rise to this diversity. Two models for skeletal myogenesis have been proposed ( Figure 1A ): (1) a serial lineage model in which a single progenitor pool expresses the Mrfs subsequently within the same lineage, and (2) a parallel lineage model in which these genes would be expressed in distinct lineages. Based on lineage tracing and conditional cell ablation studies in mice, Haldar and colleagues put forth a parallel lineage model where mutually exclusive Myf5-derived and Myod + /Myf5-independent populations exist during skeletal myogenesis. Using the same strategy, a second report arrived to similar conclusions (Gensch et al., 2008) . Notably, Mrf4 expression was reported to be unchanged or even reduced in Myf5
Cre -DTA early and late stage embryos (Gensch et al., 2008; Haldar et al., 2008) , and this was verified in the present study ( Figures S5C and S5D) , thereby ruling out a compensatory role for this determination gene (Kassar-Duchossoy et al., 2004) in the muscle rescue observed. Therefore, the authors concluded that the Myf5-lineage is dispensable for myogenesis as a Myod-lineage takes over when the Myf5-lineage is eliminated. Importantly, the observation of rescue to virtually normal myogenesis throughout the body prompted the authors to qualify the Myod + /Myf5-independent lineage as functionally relevant.
For this model to be valid, several criteria should be fulfilled. First, achievement of 100% ablation of the Myf5 lineage is an absolute requirement for proposing the existence of a second Myf5-independent lineage. Therefore, 100% efficiency of both the Cre driver and reporter/ablator lines must be assured. Second, the developmental time course of expression of the gene being evaluated should provide sufficient time for the ablation to take place. Thus, even if the window of opportunity of the gene is tight (e.g., gene being rapidly downregulated) there should be no risk of incomplete kill ( Figure 5C, see below) . (A) Note that in E10.5 Myf5 Cre -DTA embryos Cre transcripts are highly reduced and only present at the level of the forelimbs and tail, whereas Myf5 transcripts are much more prominent (black arrowheads). Myod levels are also lower than the control. The myotome is severely affected (inset).
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Using an extensive array of genetic approaches combined with genetic ablation studies on a large cohort of embryos, we obtained several lines of evidence that fail to support the model of two functional separate myogenic lineages (Myf5-derived and Myod + /Myf5-independent) that drive developmental myogenesis independently of one another. First, in contrast with the previous report showing restoration to ''virtually normal myogenesis'' by early fetal stages following ablation of the Myf5-expressing cell population, we observed severe and consistent loss of skeletal muscle at different anatomical locations when using the same genetic approaches. Second, we show that 100% elimination of Myf5-expressing cells in Myf5
Cre -DTA embryos is not achieved with any of the reporter mice used (one ubiquitous and two lineage specific; see below (and Gensch et al., 2008) , and they strongly point to escaper Myf5 + cells as the major contributors to myogenesis in Myf5-ablated embryos. Several factors might explain the different conclusions obtained from our studies and those performed previously. A possible key factor is the genetic background used for these types of studies. Extensive literature is available on dramatically different phenotypes obtained for genetically modified mice bred on different genetic backgrounds (http://www.jaxmice.jax.org), although phenotypes are often more severe on purebred backgrounds, which was not the case here.
We believe that the discordance with previous reports can be principally attributed to the inadequacies of genetically modified mice, as we now show using an extensive array of controls. Several studies have demonstrated incomplete recombination with different conditional reporters due to a number of factors such as the chromosomal location of floxed alleles, distance between loxP sites, sequences flanking the loxP sites, stochastic epigenetic mechanisms underlying transgene variegation, and the level of Cre activity per cell (Lewandoski, 2001; Long and Rossi, 2009; Ma et al., 2008; Nagy, 2000; Sambasivan et al., 2013; Vooijs et al., 2001) . Therefore, the interpretation of ablation studies solely based on selected reporter alleles is a high-risk task, particularly when the requirement of 100% ablation of a cell population is an obligate prerequisite for support of such a model.
In this respect, several factors can influence the interpretation of the results. First, whereas the previous studies showed loss of Cre-dependent reporter expression in Myf5
Cre -DTA embryos (using Z/EG and Z/AP conditional transgenic reporters; Gensch et al., 2008; Haldar et al., 2008) , their data did not exclude the existence of Myf5 + cells in which both the reporter and DTA allele remained unrecombined due to insufficient levels of Cre (see below). In the present study, the introduction of the Myf5 nlacZ reporter gave us the advantage of using the more sensitive b-gal activity to report Myf5 expression independently of Cre activity. In addition, we benefited from the persistence of b-gal activity as a lineage tracer at later stages to mark cells that had historically experienced Myf5 expression in progenitor cells independent of contemporary Myf5 protein expression. Second, it is now well established that the Z/EG and Z/AP reporters used in the previous studies to score ablation efficiency have the lowest sensitivity to Cre-mediated recombination, which is more problematic in cells with low levels of Cre activity (Liu et al., 2013; Ma et al., 2008; data not shown) . This is attributed to its high inter-loxP distance (Liu et al., 2013) and makes it unsuitable for tracking cell ablations, especially when it is used to demonstrate the existence of independent cell lineages. Indeed, our comparative analysis demonstrates clearly that Z/AP reporter sensitivity is a major issue ( Figure 5D ).
In the present study, we used the newer generation Rosa26-based Ai9 line, which is considered as one, if not the most, sensitive Rosa-based reporter available (Liu et al., 2013; Madisen et al., 2010) , as well as the lineage-specific Pax7 GPL line as reporters for cell ablation. We showed that while both reporters recombined efficiently, the R26 DTA fails to do so and therefore only a subpopulation of myogenic cells was efficiently ablated. Moreover, using the Pax7 GPL reporter, we showed that virtually all Pax7 + and Myod + progenitor cells are derived from Myf5-expressing cells, and given this condition, we should expect that the Myf5 Cre -DTA ablation reports in a similar manner, i.e., ablates the entire population-which is clearly not the case. These data demonstrate the existence of nonparallel recombination, i.e., different activation thresholds for individual Credependent reporters, even within a same embryo, in genetically identical cell types ( Figure 5D ).
Issues regarding transcriptional and posttranscriptional regulation of Cre transcripts could introduce other biases in the experimental outcome (Sambasivan et al., 2013; Tajbakhsh, 2009; and references therein) . This point is particularly important (legend continued on next page)
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Cell Ablations Can Confound Lineage Designations with Myf5 where its regulation, and that of the adjacent Mrf4 gene, is complicated by the presence of multiple unique and redundant modules extending over 100 kbp (reviewed in Carvajal and Rigby, 2010) . Problems related to Cre misexpression have been reported previously for other tissues (e.g., Christoffels et al., 2009; Lee et al., 2013) , and this is also likely to be a major factor leading to the misinterpretation of the genetic ablation data in the study by Haldar and (Wood et al., 2013) demonstrates a substantial reduction in the apparent level of Myf5 expression after ablation of differentiated muscle using ACTA1
Cre
. Therefore, the maintenance of Myf5 expression appears to depend on the muscle environment, as has been shown for Pax7 (Kassar-Duchossoy et al., 2005) . Hence, in this context, Cre expression would be also compromised in Myf5
Cre -DTA embryos, further confounding its ability to perform complete ablation as required by the experimental paradigm. In addition to these limitations, the fact that Myf5 is expressed briefly during lineage progression and its expression levels drop drastically from mid-embryonic development ( Figure 5C ) make this an inappropriate gene to address lineage issues of this type unless extensive analyses using reporter gene readouts are performed concomitantly. We therefore propose that DTAmediated kill occurs early in development, most likely within the initial peak of Myf5-expression, which results in complete ablation of subsets of muscles. After this time, expression of Cre (and thus DTA) is not sufficient to allow 100% elimination of Myf5 + progenitors. Consequently, this results in cells that are (1) reporter-recombined but not ablated, or (2) neither ablated nor reporter-recombined; the latter standing as the presumed ''Myod + /Myf5-independent lineage.'' We speculate that the second wave of embryogenesis in the trunk, correlating to progenitor cells arising from the central dermomyotome in somites, is less efficiently ablated likely due to the more rapid differentiation kinetics and downregulation of Myf5 following the onset of Myod expression (Tajbakhsh and Buckingham, 2000) . Furthermore, differentiated muscle fibers were found to be reporter-positive in Myf5
Cre -DTA fetuses, hence derived from Myf5-expressing nonablated progenitors. Given that Myf5 is not expressed after differentiation, these muscles will no longer be eliminated by the DTA. Therefore, because only a brief window of opportunity (Tajbakhsh and Buckingham, 2000) is available during lineage progression for Cre to recombine loxP sites from the generic Rosa locus ( Figure 5C ), it is not surprising that a Myf5 Cre -DTA ablation strategy gives misleading results. This is not the case for Myod where expression of this gene persists during lineage progression, even after permanent cell cycle exit and differentiation. Consistent with this, a recent report showed that ablation of Myod-expressing cells results in loss of myofibers and myogenic progenitors (defined by Pax7 and Myf5 expression) by E12.5 (Wood et al., 2013) . In summary, the extensive genetic data that we now provide are in discordance with the notion of a functionally significant Myod + /Myf5-independent lineage. Determining whether rescue of myogenesis in these embryos is driven exclusively by expansion of nonkilled Myf5-derived myoblasts or also by more upstream Mrf-Pax7 + progenitors (as proposed by Wood et al., 2013) will provide important insights into mechanisms set to regulate muscle homeostasis during development. As such, our observations alter the current view on how tissuegenesis is coordinated between cell fate genes and progenitor cell populations during skeletal myogenesis. These findings could influence the interpretation of other studies in which genetic cell ablation and lineage strategies are used to assess fundamental questions in developmental and adult stem cell biology.
EXPERIMENTAL PROCEDURES
Animal Models Animals were handled as per European Community guidelines and protocols were approved by the ethics committee of the Institut Pasteur (CTEA). Cre recombinase, reporter, and ablator mouse lines were described previously: Myf5 nlacZ (Tajbakhsh et al., 1996b) , Myf5 CreCAP (Haldar et al., 2008) , Myf5
CreSOR (Tallquist et al., 2000) , Myod m1 , Pax7 GPL (Sambasivan et al., 2013) , R26 eGFP-DTA (Ivanova et al., 2005) , R26 lacZ-DTA (Brockschnieder et al., 2004) , R26 tdTomato (Ai9; Madisen et al., 2010) , R26 mTmG (Muzumdar et al., 2007) , R26R lacZ (Soriano, 1999) , Z/AP (Lobe et al., 1999) , and Mrf4 nlacZ (Kassar-Duchossoy et al, 2004) . Mice were crossed and maintained on a F1 C57/BL6:DBA2 background and genotyped by PCR. Details on mouse crosses are provided in the Supplemental Experimental Procedures.
EdU Administration In Vivo
For proliferation experiments in vivo, 5-ethyl-2 0 -deoxyuridine (EdU; Invitrogen E10187) was injected intraperitoneally to pregnant females at 30 mg/g body weight (6 mg/ml solution in 0.9% saline) twice at 5 and 2 hr before they were killed. EdU was detected using the Click-iT EdU Cell Proliferation Assay Kit (Life Technologies C10350) as per manufacturer's instructions. Figure S5 .
Antibodies
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Cell Ablations Can Confound Lineage Designations and b-galactoside (rabbit polyclonal, MP Biomedicals 08559761, 1/1,500; chicken polyclonal, Immune Systems, CGAL-45A-Z, 1/1,000). tdTomato was detected with Living Colors DsRed antibody (rabbit polyclonal, Clontech 632496, 1/100).
Immunofluorescence
Immunostaining on tissue sections was performed as described elsewhere (Sambasivan et al., 2013) with modifications (see Supplemental Experimental Procedures). Images were acquired with the following systems: a Zeiss Axioplan equipped with an Apotome and ZEN software (Carl Zeiss), a Leica SPE confocal and Leica Application Suite (LAS) software or a LSM 700 laser-scanning confocal microscope and ZEN software (Carl Zeiss). All images were assembled in Adobe Photoshop and InDesign (Adobe Systems). Some images were assembled as maximum projections derived from stacks of optical sections using ImageJ (NIH). Immunostaining on whole-mount eyeballs and limbs was performed as described elsewhere (Gré goire and Kmita, 2008; Jory et al., 2009 ) with modifications (see Supplemental Experimental Procedures).
In Situ Hybridization and X-Gal Staining X-gal staining and whole-mount in situ hybridization with digoxigenin-labeled antisense mRNA probes were performed as described previously (Tajbakhsh et al., 1997) and in the Supplemental Experimental Procedures.
Statistics
All experiments were carried out on a minimum of three embryos except where stated otherwise. The graphs were plotted and statistical analyses were performed using Graph Pad Prism and Microsoft Excel software. All data points are presented as mean ± SEM (error bars). The Student's t test (two-tailed, unpaired) was applied in all cases (*p < 0.05; **p < 0.01; ***p < 0.001) except in Figure S1G where p values were calculated by Mann-Whitney analysis. Assessment of the MyHC + muscle area/limb cross-sectional area was performed with Fiji (NIH) software as described in the Supplemental Experimental Procedures.
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